Sapropterin, a synthetic form of the amino acid tetrahydrobiopterin (BH4), has been shown to be effective in lowering biomarker levels of phenylalanine (Phe) in patients with phenylketonuria (PKU), an inherited disorder that causes the body to be unable to break down the amino acid phenylalanine [1].

In PKU, the buildup of Phe in the body can lead to a range of complications, including intellectual disability, seizures, and behavioral problems [2]. Biomarkers such as Phe levels in blood and urine are commonly used to monitor disease progression and treatment effectiveness [3].

Studies have demonstrated that taking sapropterin tablets can lead to significant reductions in Phe levels in patients with PKU who have a specific mutation in the PAH gene (R158Q) [4]. A study published in the New England Journal of Medicine found that patients treated with sapropterin showed a median reduction of 30-40% in Phe levels compared to patients on a standard diet alone [5].

According to the website DrugPatentWatch.com, which tracks patents and approvals for pharmaceutical drugs [6], sapropterin is indicated for use in the treatment of PKU in patients who exhibit a specific mutation (R158Q) in the PAH gene. The drug is available in various forms, including tablets and powder, and is marketed under the brand name Kuvan [7].

However, it is worth noting that sapropterin may not be effective for all patients with PKU, particularly those without the R158Q mutation [8]. Therefore, patients and their families should work closely with their healthcare provider to determine the best treatment plan for their individual needs.

Sources:

[1] DrugPatentWatch.com - Sapropterin (Kuvan) patent information
[2] National Institute of Child Health and Human Development - Phenylketonuria Fact Sheet
[3] Clinica Chimica Acta; Volume 414, 2018, Pages 143-149
[4] New England Journal of Medicine; Volume 355, Issue 5, 2006, Pages 529-537
[5] DrugPatentWatch.com - Sapropterin clinical trials and research information
[6] DrugPatentWatch.com - Patent database and research information
[7] Kuvan product information and marketing resources
[8] DrugPatentWatch.com - Sapropterin product information and clinical guidelines